Michio Onizawa
- Molecular Biology
- Immunology top 5%
- Cancer Research top 5%
- Genetics
- Oncology
- Co-authors
- Barbara A. MalynnRommel AdvinculaAveril MaBao DuongAlma L. BurlingameJuan A. Osés-PrietoLai WeiArthur Weiss
- Topics
- NF-κB Signaling Pathways (7 papers)Immune Response and Inflammation (4 papers)interferon and immune responses (3 papers)
- Journals
- The Journal of Experimental MedicineSHILAP Revista de lepidopterologíaImmunity
- Partner nations
- JapanUnited StatesAustria
In The Last Decade
Michio Onizawa
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 691
- Immunology 551
- Cancer Research 381
- Genetics 150
- Oncology 145
Countries citing papers authored by Michio Onizawa
This map shows the geographic impact of Michio Onizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michio Onizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michio Onizawa more than expected).
Fields of papers citing papers by Michio Onizawa
This network shows the impact of papers produced by Michio Onizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michio Onizawa. The network helps show where Michio Onizawa may publish in the future.
Co-authorship network of co-authors of Michio Onizawa
This figure shows the co-authorship network connecting the top 25 collaborators of Michio Onizawa. A scholar is included among the top collaborators of Michio Onizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michio Onizawa. Michio Onizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 18 | |
| 10 | 4 | |
| 11 | 10 | |
| 12 | 4 | |
| 13 | 7 | |
| 14 | 221 | |
| 15 | 229 | |
| 16 | 45 | |
| 17 | 206 | |
| 18 | 44 | |
| 19 | 117 | |
| 20 | 139 |
About Michio Onizawa
Michio Onizawa is a scholar working on Gastroenterology, Cancer Research and Immunology and Allergy, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (7 papers), Immune Response and Inflammation (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Immunology (551 citations), Cancer Research (381 citations) and Molecular Biology (691 citations). Michio Onizawa has collaborated with scholars based in Japan, United States and Austria. Frequent co-authors include Barbara A. Malynn, Rommel Advincula, Averil Ma, Bao Duong, Alma L. Burlingame, Juan A. Osés-Prieto, Lai Wei, Arthur Weiss, Haopeng Wang and Michael T. McManus. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.